Personalized blood clot prevention for hip or knee replacement
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial compares a personalized approach to preventing blood clots after hip or knee replacement surgery with the standard one-size-fits-all method. The goal is to see if tailoring prevention to each patient works better and is safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a planned (not emergency) hip or knee replacement.
- You are 18 years or older.
- You are not currently taking blood thinners (like Lovenox, Eliquis, Xarelto, or warfarin).
- You do not have an active cancer that required treatment in the last 6 months (except minor skin cancers).
- You can speak and understand Dutch well enough to participate.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection called SRSD107 to see if it prevents blood clots after knee replacement surgery, compared to a standard blood thinner (enoxaparin). It might be an option if you are having a planned knee replacement and are otherwise healthy.
This study looks at a prevention plan to reduce the risk of hospital-acquired blood clots. It may help people who are expected to stay in the hospital for several days but do not already have a clot.
This Phase 2 study tests the best dose of low-dose aspirin to help prevent dangerous blood clots after total hip or knee replacement surgery. If you’re at lower clot risk and can safely take aspirin, it may help reduce clot risk while you recover.
This trial tests whether giving medicine to prevent blood clots during varicose vein treatment is safe and helpful. It focuses on people having a minimally invasive procedure on enlarged leg veins under local anesthesia.
This trial tests a computerized tool that helps doctors decide who needs prevention medicines to lower the risk of blood clots after a hospital stay. It may help reduce preventable clotting risk for people who are less mobile and have added risk factors.
This trial tests whether a personalized plan for blood thinners after TAVI can reduce the risk of stroke or bleeding better than the current standard of one daily blood thinner. If you've had a successful TAVI and don't need specific other blood thinners, you might be able to join.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.